Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash & Current Investments: 2019-2025

Historic Cash & Current Investments for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $65.6 million.

  • Burning Rock Biotech's Cash & Current Investments fell 7.61% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 44.66%. This contributed to the annual value of $71.5 million for FY2024, which is 17.44% down from last year.
  • Burning Rock Biotech's Cash & Current Investments amounted to $65.6 million in Q3 2025, which was down 85.58% from $455.0 million recorded in Q2 2025.
  • Burning Rock Biotech's Cash & Current Investments' 5-year high stood at $1.0 billion during Q3 2022, with a 5-year trough of $65.6 million in Q3 2025.
  • In the last 3 years, Burning Rock Biotech's Cash & Current Investments had a median value of $125.2 million in 2023 and averaged $303.6 million.
  • In the last 5 years, Burning Rock Biotech's Cash & Current Investments skyrocketed by 12,317.66% in 2021 and then plummeted by 90.01% in 2024.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Cash & Current Investments stood at $234.6 million in 2021, then plummeted by 42.82% to $134.2 million in 2022, then crashed by 35.41% to $86.7 million in 2023, then fell by 17.44% to $71.5 million in 2024, then declined by 7.61% to $65.6 million in 2025.
  • Its Cash & Current Investments stands at $65.6 million for Q3 2025, versus $455.0 million for Q2 2025 and $497.4 million for Q1 2025.